Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23331)

• Formulation Name: Dronedarone Hydrochloride eq 400mg base tablet
• Company: Sanofi Aventis Us

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Dronedarone	(DMA8FS5)	Angina pectoris	BA40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Crospovidone	(E00626)	Not Available	Disintegrant
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Hypromellose	(E00634)	Not Available	Coating agent
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Poloxamer 407	(E00646)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Polyethylene glycol 6000	(E00655)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Pregelatinized starch	(E00674)	Not Available	Binding agent; Diluent; Disintegrant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent